Recently, we’ve put together a list of the 12 Healthcare Stocks with Insider Buying in 2025. Among these is SS Innovations International, Inc.
SS Innovations International, Inc. (NASDAQ:SSII) is making strides in affordable surgical robotics through its SSi Mantra system, which presents a budget-friendly option compared to established systems like Intuitive Surgical’s da Vinci. This system has been approved in several countries, such as India, Indonesia, and the Philippines, as the company seeks regulatory nods in the U.S. and Europe to broaden its reach.
In September 2025, Naveen Kumar Amar joined as Chief Financial Officer, leveraging his extensive experience in international finance as SSII accelerates sales and gears up for submissions for a U.S. FDA 510(k) application by October, alongside CE mark certification in Europe anticipated in the first half of 2026.
From a financial perspective, SS Innovations International, Inc. (NASDAQ:SSII) experienced remarkable growth in Q2 2025, with revenues climbing by 121.8% to $10 million and gross profits more than tripling compared to the previous year. Installations of the SSi Mantra system soared by 130% year-over-year, raising the total number of installed systems to 105, which collectively facilitated 4,657 surgeries as of June 30, 2025. Among its notable achievements, the company conducted the world’s first intercontinental robotic cardiac telesurgery in July 2025, underlining its technological prowess.
Despite the promising outlook for SSII as an investment, we find that certain AI stocks may provide more significant upside potential and less risk. If you’re interested in discovering an exceptionally undervalued AI stock poised to benefit from Trump-era tariffs and the trend of onshoring, take a look at our complimentary report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy NOW
Disclosure: None.
